MEDICINE & HEALTHEven after being fully vaccinated with mRNA vaccines, which are regarded to be the most effective, transplant patients cannot generate antibodies against the coronavirus.
A recent study published in The New England Journal of Medicine confirms that the Pfizer vaccine works effectively against the COVID-19 delta variant, with a whopping 88% efficacy.
COVID-19 vaccines are shown to be strongly effective in preempting symptomatic, clinically apparent disease, and most specifically the rise of the COVID-19 Delta variant.
New research recently demonstrated the possible efficacy of an inhalable COVID-19 vaccine, one of the many vaccines in development designed to be given through a nasal spray.
Recent updates report 50 states, including Washington DC, are already infected with the COVID-19 delta variant. Experts recommend that people get vaccinated for protection against the virus.
Phase 1 of the randomized clinical trials regarding the edible rice vaccine against cholera had been a success. Further trials are expected for the cholera vaccines to be produced to combat the deadly cholera bacteria.
Researchers recently developed a technology for COVID-19, something that will enable them to study the virus, particularly its evolution inside the test tube.
Brazilian city Serrana residents have regained hope after researchers recently vaccinated nearly its whole adult population via the "Project S" in a city-wide vaccination experiment this spring.
University of Pennsylvania researchers made a drug known as diABZI, showed potent activity against the SARS-CoV-2, including the South African variant B.1.351, a Variant of Concern.
Almost 90 percent of the cancer patients had tested positive with the coronavirus antibodies after they were given shots of Pfizer-BioNTech's vaccine. In just a span of two weeks, those who obtained the second dose are proven to receive the vaccine well.
European drug manufacturers Sanofi and GlaxoSmithKline or GSK announced yesterday that they are launching large-scale clinical trials for their new COVID-19 vaccines.
Reports linking AstraZeneca's coronavirus vaccine to an extremely rare form of blood clot has spotlighted the symptoms of blood clots. What should you be looking out for?
A recent study by the CDC confirms that fully vaccinated people are not required to wear a mask. This lifts the mask mandate and further proves the effectiveness of vaccines, specifically from Pfizer and Moderna.
Experts say mixing the AstraZeneca and Pfizer COVID-19 vaccines could have more side effects, but could it also mean double the protection against the virus?
Scientists warn that a year of virtually no flu could mean that more people are susceptible in the next season. Vaccines will still be key in preventing infection.
Pfizer's COVID-19 antiviral drug may be available by the end of this year. The drug may stop COVID-19 from reproducing in the patient's nose, throat, and lungs.
Pfizer CEO Albert Bourla said that a booster shot of the COVID-19 vaccine is likely needed within 12 months to get fully vaccinated. He added that annual revaccination might be needed, like flu shots.